Guest guest Posted April 8, 2010 Report Posted April 8, 2010 " It is clear that the beneficiaries of APA's expansionist DSM-V revisions are those with vested financial stakes in maintaining high volume sales of clinically dubious, but highly profitable drugs. " *The Power Of NO Versus Psychiatry's Massive Overtreatment <http://www.theoneclickgroup.co.uk/news.php?start=3380 & end=3400 & view=yes & id=4568\ #newspost>* New York Times columnist, Leonhardt, applauds the new Medicare policy inaugurating comparative risk/ benefit analyses of medical treatments as a means of reducing healthcare costs--and also to reduce risks of serious side-effects from unnecessary treatments. He notes that " unnecessary care causes a lot of pain and even death. " Dr Frances, Prof. Emeritus, former chairman of psychiatry, Duke University and the DSM-IV Task Force warns that the American Psychiatric Association's effort to expand its reach by pathologizing those it deems " at risk " could lead to a public health catastrophe and no field trial could possibly justify its inclusion as an official diagnosis. It is clear that the beneficiaries of APA's expansionist DSM-V revisions are those with vested financial stakes in maintaining high volume sales of clinically dubious, but highly profitable drugs. *Vera Hassner Sharav, AHRP * Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.